Abstract
The conference was the first of its kind in a series of trend-setting conferences conceived and organized by Select Biosciences. The word ‘probe’ is a broad term that can be interpreted to mean any one of a wide variety of agents. These include active chemistries discovered in academic screening laboratories or in government organizations (Molecular Libraries Probe Production Centers Network or the US NIH), commercially available probes (i.e., dyes, antibodies or fluorescent proteins), failed drug candidates from the pharmaceutical industry, whole-body or cellular imaging agents, specific biomarkers or tool molecules from chemogenomics and/or systems biology efforts. The conference attendees represented academia, biotech and pharma, the speaker list was stellar, and the conference organizers succeeded in bringing together all of the various incarnations of probe hunters in order to share their experiences and to network with a common purpose.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.